about
Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 pediatric patients with thrombocytopenia unrelated to RCC.Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphomaSUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.Prognostic impact of C-REL expression in diffuse large B-cell lymphoma.NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma.Optimal Diagnostic Yield Achieved With On-site Pathology Evaluation of Fine-Needle Aspiration-Assisted Core Biopsies for Pediatric Osseous Lesions: A Single-Center Experience.DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.Fine-needle aspiration cytology of T-lymphoblastic lymphoma associated FGFR1 rearrangement myeloproliferative neoplasmStandardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.Childhood nodal marginal zone lymphoma with unusual clinicopathologic and cytogenetic features for the pediatric variant: a case report.Cytogenetically cryptic and FISH-negative PML/RARA rearrangement in acute promyelocytic leukemia detected only by PCR: an exceedingly rare phenomenon.DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated LeukemiasClear cell sarcoma of soft tissue: diagnostic utility of fluorescence in situ hybridization and reverse transcriptase polymerase chain reactionPediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysisConspicuous activated lymphocytic proliferation associated with cytokine-release syndrome after CAR T-cell therapyA clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America
P50
Q33432947-FAEDA719-9A31-48C2-B2F1-CDE928D3B617Q35004941-A3CB7159-285C-46AB-B845-BDB0A1856C6AQ35556180-99F130C4-4D5F-49B3-90FF-FA3FB37D4285Q36177650-9FFCF50B-26B6-46F0-A0A9-5CE6C77A8E68Q37269036-390D6BE2-8914-4E7C-AACC-94A1BAB46414Q37614231-8E2A09C8-D52E-4A50-951B-C1D7207A6502Q38756797-1FDA5DF5-3237-4B4B-B309-2AC598C1AC05Q39181936-98BBE6FD-0774-46CA-82FB-4FD5698EFE52Q42708309-DD7EBC61-C342-40C0-9E79-608C5521475AQ42737504-412872BF-59B2-49F9-B6A7-66A1CA075C54Q48640201-ACFB96FA-129C-4A61-9D6B-6EAEA8055AD7Q53627284-59453BE0-34AC-48EC-AE8F-2FD2CC083BF9Q54221603-82483FAA-3B0B-4E24-942A-9AAB9C7C3EB5Q57238985-973C2752-3587-46D4-AE28-659610A4CA88Q80852122-1E1955DE-0FF3-4221-B3E7-C84309D6EDA1Q91090002-1F628801-B423-463D-BF7F-94193AAC3527Q91604642-7FDB8907-5C12-4C6B-A234-D87FC4D06DC4Q92104425-0C38EB1E-1A45-45D2-85F5-A42AB8719287
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Choladda V Curry
@en
Choladda V Curry
@nl
type
label
Choladda V Curry
@en
Choladda V Curry
@nl
prefLabel
Choladda V Curry
@en
Choladda V Curry
@nl
P31
P496
0000-0003-4783-6991